BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.23
+0.23 (4.60%)
Sep 18, 2025, 2:22 PM EDT - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $187.50 million as of September 18, 2025.
Market Cap
187.50M
Enterprise Value
-125.41M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.23
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $187.50M, a decrease of -69.51%. That is a compound annual growth rate of -70.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 179.25M | -13.64% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |